Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Positron-Emission Tomography”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01826227
What this trial is testing

Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian TubePrimary Peritoneal
Memorial Sloan Kettering Cancer Center 5
Not applicableStudy completedNCT05430841
What this trial is testing

Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT

Who this might be right for
Gastric CancerPancreatic CancerLiver Cancer
The First Affiliated Hospital of Xiamen University 120
Not applicableEnded earlyNCT01052766
What this trial is testing

Breathing Synchronized PET/CT Scans for the Detection of Malignant Lung & Liver Lesions and Assessment of Tumor Glycolysis

Who this might be right for
Lung CancerNon-small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center 11
Not applicableStudy completedNCT02761356
What this trial is testing

The Added Value of Hybrid Functional Anatomical Imaging PET-CT and SPECT-CT in Patients Treated With Y-90 SIRT for Liver Malignancies

Who this might be right for
Primary Liver Tumor, Metastatic Liver
Tel-Aviv Sourasky Medical Center 50
Early research (Phase 1)Study completedNCT06129422
What this trial is testing

Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Nihon Medi-Physics Co., Ltd. 10
Very early researchUnknownNCT05638256
What this trial is testing

68Ga-labeled NY104 PET Imaging in Patients

Who this might be right for
Renal Cell Carcinoma
Affiliated Hospital of Jiangnan University 10
Very early researchActive Not RecruitingNCT05279027
What this trial is testing

Zr89 + PET Companion Trial

Who this might be right for
Melanoma (Skin)
Abramson Cancer Center at Penn Medicine 6
Early research (Phase 1)Study completedNCT01266954
What this trial is testing

An Open Label Study To Investigate the Pharmacokinetics and Pharmacodynamics of Repeat Escalating Doses of the Oral AKT Inhibitor GSK2141795 by 18F FDG PET Analysis in Subjects With Ovarian Cancer

Who this might be right for
Solid Tumours
GlaxoSmithKline 36
Testing effectiveness (Phase 2)UnknownNCT05286840
What this trial is testing

64Cu-SAR-bisPSMA Positron Emission Tomography of Patients With Known or Suspected Prostate Cancer

Who this might be right for
Prostate Cancer
Luke Nordquist, MD 150
Not applicableStudy completedNCT01993160
What this trial is testing

18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University Health Network, Toronto 50
Testing effectiveness (Phase 2)Looking for participantsNCT07593976
What this trial is testing

Evaluation of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT for Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in HER2 Positive Early Breast Cancer

Who this might be right for
Breast Cancer
Centre Henri Becquerel 42
Not applicableWithdrawnNCT01672918
What this trial is testing

Fluorodeoxyglucose Imaging Studies to Detect Lymphoma

Who this might be right for
Autoimmune Lymphoproliferative SyndromeLymphoma
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableUnknownNCT00759382
What this trial is testing

Prognostic Role of Primary Non Small Cell Lung Carcinoma Standardized F18-FDG Uptake Values (SUV and TLG) Measured With F18-fluorodeoxyglucose Positron Emission Tomography (F18-FDG-PET): a Non Interventional Study.

Who this might be right for
Non Small Cell Lung Carcinoma
European Lung Cancer Working Party 340
Testing effectiveness (Phase 2)UnknownNCT05820724
What this trial is testing

PSMA PET Scan and mpMRI for Prostate Cancer Detection

Who this might be right for
Prostate Cancer Diagnosis
VA Greater Los Angeles Healthcare System 100
Post-approval studies (Phase 4)Ended earlyNCT02109289
What this trial is testing

Etanercept in Rheumatoid Arthritis and Vascular Inflammation

Who this might be right for
Rheumatoid ArthritisVascular Inflammation
Innovaderm Research Inc. 5
Not applicableNo Longer AvailableNCT04800068
What this trial is testing

Expanded Access [Ga-68] PSMA-11 PET Imaging

Who this might be right for
Prostate Cancer
Mayo Clinic
Early research (Phase 1)Ended earlyNCT04258592
What this trial is testing

18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors

Who this might be right for
Neural Crest TumorNeuroendocrine Tumors
Universitaire Ziekenhuizen KU Leuven 6
Not applicableNot Yet RecruitingNCT06430411
What this trial is testing

Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study

Who this might be right for
Prostate Cancer MetastaticProstate Cancer Metastatic to BoneProstate Cancer+3 more
Medical University of Vienna 500
Not applicableUnknownNCT01865058
What this trial is testing

The Use of PET for the Early Response Evaluation in Patients With Diffuse Large B-cell Lymphoma.

Who this might be right for
Diffuse Large B-cell Lymphoma
Odense University Hospital 50
Not applicableLooking for participantsNCT06956144
What this trial is testing

Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients

Who this might be right for
TumorCarbonic Anhydrase IX
The First Affiliated Hospital of Xiamen University 113
Next Page